Asia Pacific Exosome Diagnostic and Therapeutic Market Size, Share & Industry Trends Analysis Report By Application (Diagnostic and Therapeutic), By Product (Reagent, Instrument, and Software), By End User, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Exosome Diagnostic and Therapeutic Market would witness market growth of 27.1% CAGR during the forecast period (2022-2028).

One of the major factors affecting the exosome diagnostic and therapeutic market demand in the next years is the rising prevalence of chronic disease and the need for screening and diagnosis. One of the major elements driving demand for this industry is exosomes' strong medicinal potential. Another factor driving demand for this market across various regions is the establishment of an explicit method for the investigation of exosome-specific proteins. Furthermore, the rising demand for additional development and research activities, which is further encouraged by government policies around the world, is one of the major factors driving this market's demand upward. The rising adoption of exosomes based on CTC and CTDNA is one of the primary factors impacting the market's growth.

China's rapid socioeconomic development has had a significant impact on its way of life. As a result of these changes in lifestyle, urbanization, and population aging, the risk of cardiovascular disease (CVD) has increased. CVD incidence has been steadily rising, and this upward trend is expected to continue in the coming decade. CVD has become a serious public health concern due to its increasing prevalence. Rising cardiovascular disease cases have necessitated innovative diagnostic and therapeutic techniques.

Since 2006, China's CVD prevalence has been steadily increasing. Stroke, coronary heart disease (CHD), pulmonary heart disease, heart failure (HF), rheumatic heart disease, congenital heart disease, and hypertension affect 13 million, 11 million, 5 million, 4.5 million, 2.5 million, 2 million, and 245 million of the 290 million persons with CVD, respectively. In terms of mortality, CVD is responsible for two out of every five fatalities in China, which is higher than the death rate from cancer or other diseases.

The China market dominated the Asia Pacific Exosome Diagnostic and Therapeutic Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $115.1 million by 2028. The Japan market is experiencing a CAGR of 26.4% during (2022 - 2028). Additionally, The India market would exhibit a CAGR of 27.9% during (2022 - 2028).

Based on Application, the market is segmented into Diagnostic and Therapeutic. Based on Product, the market is segmented into Reagent, Instrument, and Software. Based on End User, the market is segmented into Cancer Institute, Hospital, Diagnostic Center, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Exosome Diagnostic and Therapeutic Market is Projected to reach USD 1.4 Billion by 2028, at a CAGR of 26.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., Aethlon Medical, Inc., Capricor Therapeutics, Inc., Malvern Panalytical Ltd., NanoSomix, Inc., System Biosciences, LLC, and NX Pharmagen, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Diagnostic
• Therapeutic

By Product

• Reagent
• Instrument
• Software

By End User

• Cancer Institute
• Hospital
• Diagnostic Center
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Bio-Techne Corporation
• Qiagen N.V.
• Thermo Fisher Scientific, Inc.
• Aethlon Medical, Inc.
• Capricor Therapeutics, Inc.
• Malvern Panalytical Ltd.
• NanoSomix, Inc.
• System Biosciences, LLC
• NX Pharmagen, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Exosome Diagnostic and Therapeutic Market, by Application
1.4.2 Asia Pacific Exosome Diagnostic and Therapeutic Market, by Product
1.4.3 Asia Pacific Exosome Diagnostic and Therapeutic Market, by End User
1.4.4 Asia Pacific Exosome Diagnostic and Therapeutic Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Exosome Diagnostic and Therapeutic Market

Chapter 4. Asia Pacific Exosome Diagnostic and Therapeutic Market by Application
4.1 Asia Pacific Diagnostic Market by Country
4.2 Asia Pacific Therapeutic Market by Country

Chapter 5. Asia Pacific Exosome Diagnostic and Therapeutic Market by Product
5.1 Asia Pacific Reagent Market by Country
5.2 Asia Pacific Instrument Market by Country
5.3 Asia Pacific Software Market by Country

Chapter 6. Asia Pacific Exosome Diagnostic and Therapeutic Market by End User
6.1 Asia Pacific Cancer Institute Market by Country
6.2 Asia Pacific Hospital Market by Country
6.3 Asia Pacific Diagnostic Center Market by Country
6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Exosome Diagnostic and Therapeutic Market by Country
7.1 China Exosome Diagnostic and Therapeutic Market
7.1.1 China Exosome Diagnostic and Therapeutic Market by Application
7.1.2 China Exosome Diagnostic and Therapeutic Market by Product
7.1.3 China Exosome Diagnostic and Therapeutic Market by End User
7.2 Japan Exosome Diagnostic and Therapeutic Market
7.2.1 Japan Exosome Diagnostic and Therapeutic Market by Application
7.2.2 Japan Exosome Diagnostic and Therapeutic Market by Product
7.2.3 Japan Exosome Diagnostic and Therapeutic Market by End User
7.3 India Exosome Diagnostic and Therapeutic Market
7.3.1 India Exosome Diagnostic and Therapeutic Market by Application
7.3.2 India Exosome Diagnostic and Therapeutic Market by Product
7.3.3 India Exosome Diagnostic and Therapeutic Market by End User
7.4 South Korea Exosome Diagnostic and Therapeutic Market
7.4.1 South Korea Exosome Diagnostic and Therapeutic Market by Application
7.4.2 South Korea Exosome Diagnostic and Therapeutic Market by Product
7.4.3 South Korea Exosome Diagnostic and Therapeutic Market by End User
7.5 Singapore Exosome Diagnostic and Therapeutic Market
7.5.1 Singapore Exosome Diagnostic and Therapeutic Market by Application
7.5.2 Singapore Exosome Diagnostic and Therapeutic Market by Product
7.5.3 Singapore Exosome Diagnostic and Therapeutic Market by End User
7.6 Malaysia Exosome Diagnostic and Therapeutic Market
7.6.1 Malaysia Exosome Diagnostic and Therapeutic Market by Application
7.6.2 Malaysia Exosome Diagnostic and Therapeutic Market by Product
7.6.3 Malaysia Exosome Diagnostic and Therapeutic Market by End User
7.7 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market
7.7.1 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Application
7.7.2 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Product
7.7.3 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by End User

Chapter 8. Company Profiles
8.1 Bio-Techne Corporation (Exosome Diagnostic, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Qiagen N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Aethlon Medical, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expenses
8.5 Capricor Therapeutics, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.6 Malvern Panalytical Ltd. (Spectris plc)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.7 Nanosomix, Inc.
8.7.1 Company Overview
8.8 System Biosciences, LLC
8.8.1 Company Overview
8.9 NX Pharmagen, Inc. (NX Prenatal, Inc.)
8.9.1 Company Overview

TABLE 1 Asia Pacific Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Diagnostic Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Diagnostic Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Reagent Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Reagent Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Instrument Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Instrument Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Software Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Software Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Cancer Institute Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Cancer Institute Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Diagnostic Center Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Diagnostic Center Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 29 China Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 30 China Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 31 China Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 32 China Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 33 China Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 34 China Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 35 China Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 36 China Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 37 Japan Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 38 Japan Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 39 Japan Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 40 Japan Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 41 Japan Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 42 Japan Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 43 Japan Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 44 Japan Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 45 India Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 46 India Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 47 India Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 48 India Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 49 India Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 50 India Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 51 India Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 52 India Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 53 South Korea Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 54 South Korea Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 55 South Korea Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 56 South Korea Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 57 South Korea Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 58 South Korea Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 59 South Korea Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 60 South Korea Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 61 Singapore Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 62 Singapore Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 63 Singapore Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 64 Singapore Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 65 Singapore Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 66 Singapore Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 67 Singapore Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 68 Singapore Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 69 Malaysia Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 70 Malaysia Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 71 Malaysia Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 72 Malaysia Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 73 Malaysia Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 74 Malaysia Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 75 Malaysia Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 76 Malaysia Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 77 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 78 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 85 key information – Bio-Techne Corporation
TABLE 86 Key Information – Qiagen N.V.
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 Key Information – Aethlon Medical, Inc.
TABLE 89 Key Information – Capricor Therapeutics, Inc.
TABLE 90 Key Information – Malvern Panalytical Ltd
TABLE 91 Key Information – Nanosomix, Inc.
TABLE 92 Key Information – System Biosciences, LLC
TABLE 93 Key Information – NX Pharmagen, Inc.

List of Figures
FIG 1 Methodology for the research